journal
https://read.qxmd.com/read/36964624/psychometric-evaluation-of-the-indolent-systemic-mastocytosis-symptom-assessment-form-ism-saf-%C3%A2-and-determination-of-a-threshold-score-for-moderate-symptoms
#1
JOURNAL ARTICLE
Alan L Shields, Fiona Taylor, Roger E Lamoureux, Brad Padilla, Kas Severson, Tanya Green, Anthony L Boral, Cem Akin, Frank Siebenhaar, Brenton Mar
BACKGROUND: The Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) (©Blueprint Medicines Corporation), a 12-item daily diary that assesses 11 signs and symptoms of indolent systemic mastocytosis (ISM) and smoldering systemic mastocytosis (SSM), was psychometrically evaluated among patients with ISM. Additionally, thresholds of the ISM-SAF total symptom score (TSS) to distinguish patients with moderate to severe symptoms from those with mild symptoms were evaluated. METHODS: The ISM-SAF was completed daily as an electronic diary in a prospective, observational study utilizing an online survey of patients with ISM in the United States...
March 25, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36964621/the-phenotypic-spectrum-of-terminal-and-subterminal-6p-deletions-based-on-a-social-media-derived-cohort-and-literature-review
#2
JOURNAL ARTICLE
Eleana Rraku, Wilhelmina S Kerstjens-Frederikse, Morris A Swertz, Trijnie Dijkhuizen, Conny M A van Ravenswaaij-Arts, Aafke Engwerda
BACKGROUND: Terminal 6p deletions are rare, and information on their clinical consequences is scarce, which impedes optimal management and follow-up by clinicians. The parent-driven Chromosome 6 Project collaborates with families of affected children worldwide to better understand the clinical effects of chromosome 6 aberrations and to support clinical guidance. A microarray report is required for participation, and detailed phenotype information is collected directly from parents through a multilingual web-based questionnaire...
March 24, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36964591/correction-qualitative-analysis-of-patient-interviews-on-the-burden-of-neuronopathic-gaucher-disease-in-japan
#3
Yuta Koto, Aya Narita, Shinichi Noto, Midori Ono, Anna Lissa Hamada, Norio Sakai
No abstract text is available yet for this article.
March 24, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36959587/comprehensive-analysis-of-autophagy-related-gene-expression-profiles-identified-five-gene-biomarkers-associated-with-immune-infiltration-and-advanced-plaques-in-carotid-atherosclerosis
#4
JOURNAL ARTICLE
Chi Ma, Taoyuan Lu, Yanyan He, Dehua Guo, Lin Duan, Rufeng Jia, Dongyang Cai, Tao Gao, Zhongcan Chen, Binghua Xue, Tianxiao Li, Yingkun He
BACKGROUND: Autophagy plays an important role in the progression of carotid atherosclerosis (CAS). This study aimed to identify hub autophagy-related genes (ATGs) associated with CAS. METHODS: GSE43292 and GSE28829 datasets of early and advanced CAS plaques were enrolled from the Gene Expression Omnibus (GEO) database. A comprehensive analysis of differentially expressed ATGs (DE-ATGs) was conducted. Functional enrichment assay was used to explore biological functions of DE-ATGs...
March 23, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36949521/the-role-of-sirt1-level-and-sirt1-gene-polymorphisms-in-optic-neuritis-patients-with-multiple-sclerosis
#5
JOURNAL ARTICLE
Aleksandra Kubiliute, Greta Gedvilaite, Alvita Vilkeviciute, Loresa Kriauciuniene, Akvile Bruzaite, Dalia Zaliuniene, Rasa Liutkeviciene
THE AIM: To investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS). METHODS: 79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into 2 subgroups: patients with MS (n = 30) and patients without MS (n = 43). 6 ON patients did not have sufficient data for MS diagnosis and were excluded from the subgroup analysis...
March 22, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36949506/sources-of-variation-in-estimates-of-duchenne-and-becker-muscular-dystrophy-prevalence-in-the-united-states
#6
JOURNAL ARTICLE
Nedra Whitehead, Stephen W Erickson, Bo Cai, Suzanne McDermott, Holly Peay, James F Howard, Lijing Ouyang
BACKGROUND: Direct estimates of rare disease prevalence from public health surveillance may only be available in a few catchment areas. Understanding variation among observed prevalence can inform estimates of prevalence in other locations. The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) conducts population-based surveillance of major muscular dystrophies in selected areas of the United States. We identified sources of variation in prevalence estimates of Duchenne and Becker muscular dystrophy (DBMD) within MD STARnet from published literature and a survey of MD STARnet investigators, then developed a logic model of the relationships between the sources of variation and estimated prevalence...
March 22, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36944981/glut1-ds-italian-registry-past-present-and-future-a-useful-tool-for-rare-disorders
#7
JOURNAL ARTICLE
Costanza Varesio, Valentina De Giorgis, Pierangelo Veggiotti, Nardo Nardocci, Tiziana Granata, Francesca Ragona, Ludovica Pasca, Martina Maria Mensi, Renato Borgatti, Sara Olivotto, Roberto Previtali, Antonella Riva, Maria Margherita Mancardi, Pasquale Striano, Mara Cavallin, Renzo Guerrini, Francesca Felicia Operto, Alice Pizzolato, Ruggero Di Maulo, Fabiola Martino, Andrea Lodi, Carla Marini
BACKGROUND: GLUT1 deficiency syndrome is a rare, genetically determined neurological disorder for which Ketogenic Dietary Treatment represents the gold standard and lifelong treatment. Patient registries are powerful tools providing insights and real-world data on rare diseases. OBJECTIVE: To describe the implementation of a national web-based registry for GLUT1-DS. METHODS: This is a retrospective and prospective, multicenter, observational registry developed in collaboration with the Italian GLUT1-DS association and based on an innovative, flexible and configurable cloud computing technology platform, structured according to the most rigorous requirements for the management of patient's sensitive data...
March 21, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36941680/increasing-incidence-rate-of-breast-cancer-in-cystic-fibrosis-relationship-between-pathogenesis-oncogenesis-and-prediction-of-the-treatment-effect-in-the-context-of-worse-clinical-outcome-and-prognosis-of-cystic-fibrosis-due-to-estrogens
#8
REVIEW
Nela Stastna, Kristian Brat, Lukas Homola, Audun Os, Dagmar Brancikova
Cystic fibrosis (CF) is the most common genetic disease in the Caucasion population. Thanks to the CFTR modulators therapy, life expectancy will significantly improve. New therapeutic challenges can be expected, including diseases associated with ageing and higher incidence of cancer, as evidenced by recent epidemiological studies. The increasing incidence of tumors includes also breast cancer. The risk of breast cancer is higher in CF patients compared to the general population. Sex hormones, especially estrogens, also affect on the pathophysiology and immunology of the CF...
March 20, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36941608/a-follow-up-report-on-the-published-paper-social-and-clinical-impact-of-covid-19-on-patients-with-fibrodysplasia-ossificans-progressiva
#9
LETTER
Hayley Wallace, Rhonda H Lee, Edward C Hsiao
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder associated with increased immune activity and severe, progressive heterotopic ossification. We previously described a cohort of 32 patients with FOP who were either exposed to SARS-CoV-2 or received a COVID-19 vaccine1 and showed that these patients did not develop heterotopic ossification after COVID-19 vaccination. Here, we present additional clinical data from new subjects and additional long-term follow-up from the first cohort. We enrolled 15 new subjects between August 24th, 2021 and May 17th, 2022 and collected additional self-reported outcomes...
March 20, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36935495/parent-reported-phenotype-data-on-chromosome-6-aberrations-collected-via-an-online-questionnaire-data-consistency-and-data-availability
#10
JOURNAL ARTICLE
Aafke Engwerda, Barbara Frentz, Eleana Rraku, Nadia F Simoes de Souza, Morris A Swertz, Mirjam Plantinga, Wilhelmina S Kerstjens-Frederikse, Adelita V Ranchor, Conny M A van Ravenswaaij-Arts
BACKGROUND: Even with the introduction of new genetic techniques that enable accurate genomic characterization, knowledge about the phenotypic spectrum of rare chromosomal disorders is still limited, both in literature and existing databases. Yet this clinical information is of utmost importance for health professionals and the parents of children with rare diseases. Since existing databases are often hampered by the limited time and willingness of health professionals to input new data, we collected phenotype data directly from parents of children with a chromosome 6 disorder...
March 19, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36935482/the-phenotypic-spectrum-of-terminal-6q-deletions-based-on-a-large-cohort-derived-from-social-media-and-literature-a-prominent-role-for-dll1
#11
JOURNAL ARTICLE
Aafke Engwerda, Wilhelmina S Kerstjens-Frederikse, Nicole Corsten-Janssen, Trijnie Dijkhuizen, Conny M A van Ravenswaaij-Arts
BACKGROUND: Terminal 6q deletions are rare, and the number of well-defined published cases is limited. Since parents of children with these aberrations often search the internet and unite via international social media platforms, these dedicated platforms may hold valuable knowledge about additional cases. The Chromosome 6 Project is a collaboration between researchers and clinicians at the University Medical Center Groningen and members of a Chromosome 6 support group on Facebook. The aim of the project is to improve the surveillance of patients with chromosome 6 aberrations and the support for their families by increasing the available information about these rare aberrations...
March 19, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36934245/exploring-disease-perception-in-beh%C3%A3-et-s-syndrome-combining-a-quantitative-and-a-qualitative-study-based-on-a-narrative-medicine-approach
#12
JOURNAL ARTICLE
D Marinello, I Palla, V Lorenzoni, G Andreozzi, S Pirri, S Ticciati, S Cannizzo, A Del Bianco, E Ferretti, S Santoni, G Turchetti, M Mosca, R Talarico
BACKGROUND: Behçet Syndrome (BS) has a significant psychological and social impact on patients, caregivers and families. The present study aims at exploring disease perception in BS patients, using both a co-designed survey and the narrative medicine (NM) approach. METHODS: An ad-hoc questionnaire was co-designed by clinicians expert in BS, BS patients and caregivers and BS adult patients were invited to answer the online questionnaires. Cluster analysis was used to analyse data from the survey and to identify groups of patients with diverse disease perception...
March 18, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36927364/brain-malformations-in-diprosopia-observed-in-clinical-cases-museum-specimens-and-artistic-representations
#13
JOURNAL ARTICLE
Helga Rehder, Susanne G Kircher, Katharina Schoner, Mateja Smogavec, Jana Behunova, Ulrike Ihm, Margit Plassmann, Manuel Hofer, Helmut Ringl, Franco Laccone
BACKGROUND: Diprosopus is a rare malformation of still unclear aetiology. It describes a laterally double faced monocephalic and single-trunk individual and has to be distinguished from the variant Janus type diprosopus. RESULTS: We examined seven double-faced foetuses, five showing true diprosopus, and one each presenting as monocephalic Janiceps and parasitic conjoined twins. Four of the foetuses presented with (cranio)rachischisis, and two had secondary hydrocephaly...
March 16, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36922864/lifetime-impact-of-achondroplasia-study-in-europe-liaise-findings-from-a-multinational-observational-study
#14
JOURNAL ARTICLE
Mohamad Maghnie, Oliver Semler, Encarna Guillen-Navarro, Angelo Selicorni, Karen E Heath, Gabriele Haeusler, Lars Hagenäs, Andrea Merker, Antonio Leiva-Gea, Vanesa López González, Adalbert Raimann, Mirko Rehberg, Fernando Santos-Simarro, Diana-Alexandra Ertl, Pernille Axél Gregersen, Roberta Onesimo, Erik Landfeldt, James Jarrett, Jennifer Quinn, Richard Rowell, Jeanne Pimenta, Shelda Cohen, Thomas Butt, Renée Shediac, Swati Mukherjee, Klaus Mohnike
BACKGROUND: Achondroplasia, caused by a pathogenic variant in the fibroblast growth factor receptor 3 gene, is the most common skeletal dysplasia. The Lifetime Impact of Achondroplasia Study in Europe (LIAISE; NCT03449368) aimed to quantify the burden of achondroplasia among individuals across a broad range of ages, including adults. METHODS: Demographic, clinical and healthcare resource use data were collected from medical records of achondroplasia patients enrolled in 13 sites across six European countries in this retrospective, observational study...
March 15, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36918897/correction-long-term-safety-and-clinical-outcomes-of-olipudase-alfa-enzyme-replacement-therapy-in-pediatric-patients-with-acid-sphingomyelinase-deficiency-two-year-results
#15
George A Diaz, Roberto Giugliani, Nathalie Gufon, Simon A Jones, Eugen Mengel, Maurizio Scarpa, Peter Witters, Abhimanyu Yarramaneni, Jing Li, Nicole M Armstrong, Yong Kim, Catherine Ortemann-Renon, Monica Kumar
No abstract text is available yet for this article.
March 14, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36915141/correction-ketogenic-diet-as-a-glycine-lowering-therapy-in-nonketotic-hyperglycinemia-and-impact-on-brain-glycine-levels
#16
Emily Shelkowitz, Russell P Saneto, Walla Al-Hertani, Charlotte M A Lubout, Nicholas V Stence, Mark S Brown, Patrick Long, Diana Walleigh, Julie A Nelson, Francisco E Perez, Dennis W W Shaw, Emma J Michl, Johan L K Van Hove
No abstract text is available yet for this article.
March 13, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36915094/multisystem-alk-positive-histiocytosis-a-multi-case-study-and-literature-review
#17
REVIEW
Wei Liu, Hong-Jie Liu, Wei-Ya Wang, Yuan Tang, Sha Zhao, Wen-Yan Zhang, Jia-Qi Yan, Wei-Ping Liu
BACKGROUND: Anaplastic lymphoma kinase (ALK)-positive histiocytosis, a novel rare histiocytic proliferation, was first described in 2008; it occurs in early infancy with liver and hematopoietic involvement. The spectrum was subsequently broadened to include localized diseases in older children and young adults. However, its full clinicopathological features and molecular lineage have not been fully elucidated. RESULTS: Here, we report four cases of multisystem ALK-positive histiocytosis without hematopoietic involvement...
March 13, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36907859/biochemical-and-mutational-analyses-of-hexa-in-a-cohort-of-egyptian-patients-with-infantile-tay-sachs-disease-expansion-of-the-mutation-spectrum
#18
JOURNAL ARTICLE
Doaa M A Ibrahim, Ola S M Ali, Hala Nasr, Ekram Fateen, Alice AbdelAleem
BACKGROUND: Tay-Sachs disease (TSD), an autosomal recessively inherited neurodegenerative lysosomal storage disease, reported worldwide with a high incidence among population of Eastern European and Ashkenazi Jewish descent. Mutations in the alpha subunit of HEXA that encodes for the β-hexosaminidase-A lead to deficient enzyme activity and TSD phenotype. This study is the first to highlight the HEXA sequence variations spectrum in a cohort of Egyptian patients with infantile TSD...
March 13, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36906580/ocular-sequelae-of-epidermal-necrolysis-french-national-audit-of-practices-literature-review-and-proposed-management
#19
REVIEW
Dhyna Thorel, Saskia Ingen-Housz-Oro, Daniel Benaïm, Vincent Daien, Eric Gabison, Valentine Saunier, Laurence Béral, David Touboul, Dominique Brémond-Gignac, Matthieu Robert, Robin Vasseur, Gérard Royer, Olivier Dereure, Brigitte Milpied, Claire Bernier, Anne Welfringer-Morin, Christine Bodemer, Nadège Cordel, Marie Tauber, Carole Burillon, Marion Servant, Chloe Couret, Bertrand Vabres, Florence Tétart, Myriam Cassagne, Marie-Ange Kuoch, Marc Muraine, Agnès Delcampe, Julie Gueudry
Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious and rare diseases, most often drug-induced, and their incidence has been estimated at 6 cases/million/year in France. SJS and TEN belong to the same spectrum of disease known as epidermal necrolysis (EN). They are characterized by more or less extensive epidermal detachment, associated with mucous membrane involvement, and may be complicated during the acute phase by fatal multiorgan failure. SJS and TEN can lead to severe ophthalmologic sequelae...
March 11, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/36899416/increased-incidence-of-adult-onset-still-s-disease-in-association-with-covid-19-vaccination-and-sars-cov-2-infection
#20
JOURNAL ARTICLE
Maxime N Gottschalk, Max Heiland, Susanne Nahles, Robert Preissner, William A Petri, Stephanie Wendy, Saskia Preissner
BACKGROUND: Adult-onset Still's disease (AOSD) is a multi-system, auto-inflammatory disease characterized by fever, arthralgia, typical rash, leukocytosis, sore throat, and liver dysfunction, among other symptoms. Retrospective studies about the frequencies of AOSD have shown that this disease is very rare. However, there has been an increased scientific interest in the last 2 years, as numerous case studies on AOSD have been published. These case studies describe the occurrence of AOSD after SARS-CoV-2 infection and/or COVID-19 vaccination...
March 10, 2023: Orphanet Journal of Rare Diseases
journal
journal
41284
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.